Literature DB >> 11880951

Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

Nadine Puget1, Sophie Gad, Laure Perrin-Vidoz, Olga M Sinilnikova, Dominique Stoppa-Lyonnet, Gilbert M Lenoir, Sylvie Mazoyer.   

Abstract

The 5' end of the breast and ovarian cancer-susceptibility gene BRCA1 has previously been shown to lie within a duplicated region of chromosome band 17q21. The duplicated region contains BRCA1 exons 1A, 1B, and 2 and their surrounding introns; as a result, a BRCA1 pseudogene (PsiBRCA1) lies upstream of BRCA1. However, the sequence of this segment remained essentially unknown. We needed this information to investigate at the nucleotide level the germline deletions comprising BRCA1 exons 1A, 1B, and 2, which we had previously identified in two families with breast and ovarian cancer. We have analyzed the recently deposited nucleotide sequence of the 1.0-Mb region upstream of BRCA1. We found that 14 blocks of homology between the tandemly repeated copies (cumulative length = 11.5 kb) show similarity of 77%-92%. Gaps between blocks result from insertion or deletion, usually of repetitive elements. BRCA1 exon 1A and PsiBRCA1 exon 1A are 44.5 kb apart. In the two families with breast and ovarian cancer mentioned above, distinct homologous recombination events occurred between intron 2 of BRCA1 and intron 2 of PsiBRCA1, leading to 37-kb deletions. Breakpoint junctions were found to be located at close but distinct sites within segments that are 98% identical. The mutant alleles lack the BRCA1 promoter and harbor a chimeric gene consisting of PsiBRCA1 exons 1A, 1B, and 2, which lacks the initiation codon, fused to BRCA1 exons 3-24. Thus, we report a new mutational mechanism for the BRCA1 gene. The presence of a large region homologous to BRCA1 on the same chromosome appears to constitute a hot spot for recombination.

Entities:  

Mesh:

Year:  2002        PMID: 11880951      PMCID: PMC379114          DOI: 10.1086/339434

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  In-frame deletions of BRCA1 may define critical functional domains.

Authors:  E M Rohlfs; C H Chung; Q Yang; C Skrzynia; W W Grody; M L Graham; L M Silverman
Journal:  Hum Genet       Date:  2000-10       Impact factor: 4.132

2.  Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements.

Authors:  S Gad; A Aurias; N Puget; A Mairal; C Schurra; M Montagna; S Pages; V Caux; S Mazoyer; A Bensimon; D Stoppa-Lyonnet
Journal:  Genes Chromosomes Cancer       Date:  2001-05       Impact factor: 5.006

3.  Exon deletions and duplications in BRCA1 detected by semiquantitative PCR.

Authors:  M D Robinson; C E Chu; G Turner; D T Bishop; G R Taylor
Journal:  Genet Test       Date:  2000

4.  Identification of a large rearrangement of the BRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing.

Authors:  S Gad; M T Scheuner; S Pages-Berhouet; V Caux-Moncoutier; A Bensimon; A Aurias; M Pinto; D Stoppa-Lyonnet
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

5.  Recombination hotspot in NF1 microdeletion patients.

Authors:  C López-Correa; M Dorschner; H Brems; C Lázaro; M Clementi; M Upadhyaya; D Dooijes; U Moog; H Kehrer-Sawatzki; J L Rutkowski; J P Fryns; P Marynen; K Stephens; E Legius
Journal:  Hum Mol Genet       Date:  2001-06-15       Impact factor: 6.150

6.  Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.

Authors:  M Montagna; M Santacatterina; A Torri; C Menin; D Zullato; L Chieco-Bianchi; E D'Andrea
Journal:  Oncogene       Date:  1999-07-15       Impact factor: 9.867

7.  Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

Authors:  M A Unger; K L Nathanson; K Calzone; D Antin-Ozerkis; H A Shih; A M Martin; G M Lenoir; S Mazoyer; B L Weber
Journal:  Am J Hum Genet       Date:  2000-09-07       Impact factor: 11.025

8.  Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa).

Authors:  J Liu; G Prolla; A Rostagno; R Chiarle; H Feiner; G Inghirami
Journal:  Oncogene       Date:  2000-05-25       Impact factor: 9.867

9.  Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer.

Authors:  S R Payne; B Newman; M C King
Journal:  Genes Chromosomes Cancer       Date:  2000-09       Impact factor: 5.006

10.  An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10.

Authors:  E M Rohlfs; N Puget; M L Graham; B L Weber; J E Garber; C Skrzynia; J L Halperin; G M Lenoir; L M Silverman; S Mazoyer
Journal:  Genes Chromosomes Cancer       Date:  2000-07       Impact factor: 5.006

View more
  29 in total

1.  Caught red-handed: Rc encodes a basic helix-loop-helix protein conditioning red pericarp in rice.

Authors:  Megan T Sweeney; Michael J Thomson; Bernard E Pfeil; Susan McCouch
Journal:  Plant Cell       Date:  2006-01-06       Impact factor: 11.277

2.  Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers.

Authors:  G Chenevix-Trench; O M Sinilnikova; G Suthers; N Pandeya; S Mazoyer; J F Sambrook; S Goldup; D Goldgar; H T Lynch; G M Lenoir; G Cheetham
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer.

Authors:  Beata Bielinska; Pawel Gaj; Anna Kluska; Dorota Nowakowska; Aneta Balabas; Michalina Dabrowska; Anna Niwinska; Jakub Gruchota; Renata Zub; Elzbieta Skasko; Jan Steffen; Jerzy Ostrowski; Janusz A Siedlecki
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

Review 4.  Long non-coding RNAs in cancer: implications for personalized therapy.

Authors:  Marianna Vitiello; Andrea Tuccoli; Laura Poliseno
Journal:  Cell Oncol (Dordr)       Date:  2014-08-12       Impact factor: 6.730

5.  Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome.

Authors:  Paola Concolino; Roberta Rizza; Karl Hackmann; Angelo Minucci; Giovanni Luca Scaglione; Maria De Bonis; Alessandra Costella; Cecilia Zuppi; Evelin Schrock; Ettore Capoluongo
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

6.  The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene.

Authors:  Nicholas Lister; Galina Shevchenko; James L Walshe; Jessica Groen; Per Johnsson; Linda Vidarsdóttir; Dan Grander; Sandro F Ataide; Kevin V Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

7.  A transcribed pseudogene of MYLK promotes cell proliferation.

Authors:  Yoo Jeong Han; Shwu Fan Ma; Gregory Yourek; Yoon-Dong Park; Joe G N Garcia
Journal:  FASEB J       Date:  2011-03-25       Impact factor: 5.191

8.  Dealing with Pseudogenes in Molecular Diagnostics in the Next Generation Sequencing Era.

Authors:  Kathleen B M Claes; Toon Rosseel; Kim De Leeneer
Journal:  Methods Mol Biol       Date:  2021

Review 9.  An expanding universe of the non-coding genome in cancer biology.

Authors:  Bin Xue; Lin He
Journal:  Carcinogenesis       Date:  2014-04-18       Impact factor: 4.944

10.  Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.

Authors:  Tal Distelman-Menachem; Tal Shapira; Yael Laitman; Bella Kaufman; Frida Barak; Sean Tavtigian; Eitan Friedman
Journal:  Fam Cancer       Date:  2008-09-17       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.